Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Leptin-Induced Signaling Pathways in Cancer Cell Migration and Invasion Publisher Pubmed



Ghasemi A1, 2 ; Saeidi J3 ; Aziminejad M1, 4 ; Hashemy SI5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran
  2. 2. Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Physiology, School of Basic Science, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran
  4. 4. Department of Genetic, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  5. 5. Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Source: Cellular Oncology Published:2019


Abstract

Background Increasing evidence indicates that obesity is associated with tumor development and progression. Leptin is an adipocyte-related hormone with a key role in energy metabolism and whose circulating levels are elevated in obesity. The effect of leptin on cancer progression and metastasis and its underlying mechanisms are still unclear. Leptin can impact various steps in tumor metastasis, including epithelial-mesenchymal transition, cell adhesion to the extracellular matrix (ECM), and proteolysis of ECM components. To do so, leptin binds to its receptor (OB-Rb) to activate signaling pathways and downstream effectors that participate in tumor cell invasion as well as distant metastasis. Conclusions In this review, we describe metastasis steps in detail and characterize metastasis-related molecules activated by leptin, which may help to develop a roadmap that guides future work. In addition, we conclude that a profound understanding of the fundamental molecular processes that contribute to leptin-induced metastasis may pave the way for the development of new prognostic molecules and appropriate approaches to the treatment of obesity-related cancers. © International Society for Cellular Oncology 2019.